Aisling Capital Partners IV, LP, 10% Owner at Elevation Oncology, Inc. (ELEV), bought 2,080,732 shares at $16.00 ($3.0M) on 2021-06-29, disclosed to the SEC on 2021-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,893,232 | $0 | 0.0% |
| 2 | $16.00 | 187,500 | $3.0M | 100.0% |
| Total | $1.44 avg | 2,080,732 | $3.0M | 100% |